| 词条 | Tryptophan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 释义 |
| Verifiedfields = changed | verifiedrevid = 477866188 | Name = L-Tryptophan | ImageFile1 = L-Tryptophan - L-Tryptophan.svg | ImageName1 = Structure of L-isomer | IUPACName = Tryptophan or (2S)-2-amino-3-(1H-indol-3-yl)propanoic acid | OtherNames = 2-Amino-3-(1H-indol-3-yl)propanoic acid |Section1={{Chembox Identifiers | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | ChemSpiderID = 6066 | UNII_Ref = {{fdacite|correct|FDA}} | UNII = 8DUH1N11BX | ChEMBL_Ref = {{ebicite|correct|EBI}} | ChEMBL = 54976 | KEGG_Ref = {{keggcite|correct|kegg}} | KEGG = D00020 | InChI = 1/C11H12N2O2/c12-9(11(14)15)5-7-6-13-10-4-2-1-3-8(7)10/h1-4,6,9,13H,5,12H2,(H,14,15)/t9-/m0/s1 | InChIKey = QIVBCDIJIAJPQS-VIFPVBQEBP | StdInChI_Ref = {{stdinchicite|correct|chemspider}} | StdInChI = 1S/C11H12N2O2/c12-9(11(14)15)5-7-6-13-10-4-2-1-3-8(7)10/h1-4,6,9,13H,5,12H2,(H,14,15)/t9-/m0/s1 | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | StdInChIKey = QIVBCDIJIAJPQS-VIFPVBQESA-N | CASNo = 73-22-3 | CASNo_Ref = {{cascite|correct|CAS}} | PubChem = 6305 | IUPHAR_ligand = 717 | DrugBank_Ref = {{drugbankcite|correct|drugbank}} | DrugBank = DB00150 | ChEBI_Ref = | ChEBI = 16828 | SMILES = c1ccc2c(c1)c(c[nH]2)C[C@@H](C(=O)O)N | SMILES1 = c1ccc2c(c1)c(c[nH]2)C[C@@H](C(=O)[O-])[NH3+] | SMILES1_Comment = Zwitterion }} |Section2={{Chembox Properties | C=11 | H=12 | N=2 | O=2 | Appearance = | Density = | MeltingPt = | BoilingPt = | Solubility = Soluble: 0.23 g/L at 0 °C, 11.4 g/L at 25 °C, 17.1 g/L at 50 °C, 27.95 g/L at 75 °C | SolubleOther = Soluble in hot alcohol, alkali hydroxides; insoluble in chloroform. | pKa=2.38 (carboxyl), 9.39 (amino)[1] | MagSus = -132.0·10−6 cm3/mol }} |Section6={{Chembox Pharmacology | ATCCode_prefix = N06 | ATCCode_suffix = AX02 }} |Section7={{Chembox Hazards | MainHazards = | FlashPt = | AutoignitionPt = }} }} Tryptophan (symbol Trp or W)[2] is an α-amino acid that is used in the biosynthesis of proteins. Tryptophan contains an α-amino group, an α-carboxylic acid group, and a side chain indole, making it a non-polar aromatic amino acid. It is essential in humans, meaning the body cannot synthesize it: it must be obtained from the diet. Tryptophan is also a precursor to the neurotransmitter serotonin, the hormone melatonin and vitamin B3.[3] It is encoded by the codon UGG. Like other amino acids, tryptophan is a zwitterion at physiological pH where the amino group is protonated (–NH3+; pKa = 9.39) and the carboxylic acid is deprotonated ( –COO−; pKa = 2.38).[4] FunctionAmino acids, including tryptophan, are used as building blocks in protein biosynthesis, and proteins are required to sustain life. Many animals (including humans) cannot synthesize tryptophan: they need to obtain it through their diet, making it an essential amino acid. Tryptophan is among the less common amino acids found in proteins, but it plays important structural or functional roles whenever it occurs. For instance, tryptophan and tyrosine residues play special roles in "anchoring" membrane proteins within the cell membrane. In addition, tryptophan functions as a biochemical precursor for the following compounds:
The disorder fructose malabsorption causes improper absorption of tryptophan in the intestine, reduced levels of tryptophan in the blood,[10] and depression.[11] In bacteria that synthesize tryptophan, high cellular levels of this amino acid activate a repressor protein, which binds to the trp operon.[12] Binding of this repressor to the tryptophan operon prevents transcription of downstream DNA that codes for the enzymes involved in the biosynthesis of tryptophan. So high levels of tryptophan prevent tryptophan synthesis through a negative feedback loop, and when the cell's tryptophan levels go down again, transcription from the trp operon resumes. This permits tightly regulated and rapid responses to changes in the cell's internal and external tryptophan levels. {{Tryptophan metabolism by human microbiota|align=left}}{{clear}}Recommended dietary allowanceIn 2002, the U.S. Institute of Medicine set a Recommended Dietary Allowance (RDA) of 5 mg/kg body weight/day of Tryptophan for adults 19 years and over.[13] Dietary sourcesTryptophan is present in most protein-based foods or dietary proteins. It is particularly plentiful in chocolate, oats, dried dates, milk, yogurt, cottage cheese, red meat, eggs, fish, poultry, sesame, chickpeas, almonds, sunflower seeds, pumpkin seeds, buckwheat, spirulina, and peanuts. Contrary to the popular belief[14][14][16] that turkey contains an abundance of tryptophan, the tryptophan content in turkey is typical of poultry.[15]
Use as a dietary supplementBecause tryptophan is converted into 5-hydroxytryptophan (5-HTP) which is then converted into the neurotransmitter serotonin, it has been proposed that consumption of tryptophan or 5-HTP may improve depression symptoms by increasing the level of serotonin in the brain. Tryptophan is sold over the counter in the United States (after being banned to varying extents between 1989 and 2005) and the United Kingdom as a dietary supplement for use as an antidepressant, anxiolytic, and sleep aid. It is also marketed as a prescription drug in some European countries for the treatment of major depression. There is evidence that blood tryptophan levels are unlikely to be altered by changing the diet,[17][18] but consuming purified tryptophan increases the serotonin level in the brain, whereas eating foods containing tryptophan does not.[19] This is because the transport system that brings tryptophan across the blood–brain barrier also transports other amino acids which are contained in protein food sources.[23] High blood plasma levels of other large neutral amino acids prevent the plasma concentration of tryptophan from increasing brain concentration levels.[20] In 2001 a Cochrane review of the effect of 5-HTP and tryptophan on depression was published. The authors included only studies of a high rigor and included both 5-HTP and tryptophan in their review because of the limited data on either. Of 108 studies of 5-HTP and tryptophan on depression published between 1966 and 2000, only two met the authors' quality standards for inclusion, totaling 64 study participants. The substances were more effective than placebo in the two studies included but the authors state that "the evidence was of insufficient quality to be conclusive" and note that "because alternative antidepressants exist which have been proven to be effective and safe, the clinical usefulness of 5-HTP and tryptophan is limited at present".[21] The use of tryptophan as an adjunctive therapy in addition to standard treatment for mood and anxiety disorders is not supported by the scientific evidence.[21][22] Side effectsPotential side effects of tryptophan supplementation include nausea, diarrhea, drowsiness, lightheadedness, headache, dry mouth, blurred vision, sedation, euphoria, and nystagmus (involuntary eye movements).[23][24] InteractionsTryptophan taken as a dietary supplement (such as in tablet form) has the potential to cause serotonin syndrome when combined with antidepressants of the MAOI or SSRI class or other strongly serotonergic drugs.[24] Because tryptophan supplementation has not been thoroughly studied in a clinical setting, its interactions with other drugs are not well known.[21] IsolationThe isolation of tryptophan was first reported by Frederick Hopkins in 1901.[25] Hopkins recovered tryptophan from hydrolysed casein, recovering 4–8 g of tryptophan from 600 g of crude casein.[26] Biosynthesis and industrial productionAs an essential amino acid, tryptophan is not synthesized from simpler substances in humans and other animals, so it needs to be present in the diet in the form of tryptophan-containing proteins. Plants and microorganisms commonly synthesize tryptophan from shikimic acid or anthranilate:[27] anthranilate condenses with phosphoribosylpyrophosphate (PRPP), generating pyrophosphate as a by-product. The ring of the ribose moiety is opened and subjected to reductive decarboxylation, producing indole-3-glycerol phosphate; this, in turn, is transformed into indole. In the last step, tryptophan synthase catalyzes the formation of tryptophan from indole and the amino acid serine. The industrial production of tryptophan is also biosynthetic and is based on the fermentation of serine and indole using either wild-type or genetically modified bacteria such as B. amyloliquefaciens, B. subtilis, C. glutamicum or E. coli. These strains carry mutations that prevent the reuptake of aromatic amino acids or multiple/overexpressed trp operons. The conversion is catalyzed by the enzyme tryptophan synthase.[28][29][30] Society and cultureEosinophilia–myalgia syndromeThere was a large outbreak of eosinophilia-myalgia syndrome (EMS) in the U.S. in 1989, with more than 1,500 cases reported to the CDC and at least 37 deaths.[31] After preliminary investigation revealed that the outbreak was linked to intake of tryptophan, the U.S. Food and Drug Administration (FDA) recalled tryptophan supplements in 1989 and banned most public sales in 1990,[32][33][34] with other countries following suit.[35][36] Subsequent studies suggested that EMS was linked to specific batches of L-tryptophan supplied by a single large Japanese manufacturer, Showa Denko.[32][37][38][39] It eventually became clear that recent batches of Showa Denko's L-tryptophan were contaminated by trace impurities, which were subsequently thought to be responsible for the 1989 EMS outbreak.[32][40][41] However, other evidence suggests that tryptophan itself may be a potentially major contributory factor in EMS.[42] The FDA loosened its restrictions on sales and marketing of tryptophan in February 2001,[32] but continued to limit the importation of tryptophan not intended for an exempted use until 2005.[43] The fact that the Showa Denko facility used genetically engineered bacteria to produce the contaminated batches of L-tryptophan later found to have caused the outbreak of eosinophilia-myalgia syndrome has been cited as evidence of a need for "close monitoring of the chemical purity of biotechnology-derived products".[44] Those calling for purity monitoring have, in turn, been criticized as anti-GMO activists who overlook possible non-GMO causes of contamination and threaten the development of biotech.[45] Turkey meat and drowsiness{{See also|Postprandial somnolence#Turkey and tryptophan}}A common assertion in the US is that heavy consumption of turkey meat results in drowsiness, due to high levels of tryptophan contained in turkey.[46][47] However, the amount of tryptophan in turkey is comparable to that contained in other meats.[14][15] Drowsiness after eating may be caused by other foods eaten with the turkey, particularly carbohydrates.[48] Ingestion of a meal rich in carbohydrates triggers the release of insulin.[49][50][51][52] Insulin in turn stimulates the uptake of large neutral branched-chain amino acids (BCAA), but not tryptophan, into muscle, increasing the ratio of tryptophan to BCAA in the blood stream. The resulting increased tryptophan ratio reduces competition at the large neutral amino acid transporter (which transports both BCAA and aromatic amino acids), resulting in more uptake of tryptophan across the blood–brain barrier into the cerebrospinal fluid (CSF).[53][54][52] Once in the CSF, tryptophan is converted into serotonin in the raphe nuclei by the normal enzymatic pathway.[55][50] The resultant serotonin is further metabolised into melatonin by the pineal gland.[7] Hence, these data suggest that "feast-induced drowsiness"—or postprandial somnolence—may be the result of a heavy meal rich in carbohydrates, which indirectly increases the production of melatonin in the brain, and thereby promotes sleep.[55][49][50][51] ResearchIn 1912 Felix Ehrlich demonstrated that yeast attacks the natural amino acids essentially by splitting off carbon dioxide and replacing the amino group with hydroxyl. By this reaction, tryptophan gives rise to tryptophol.[56] Tryptophan affects brain serotonin synthesis when given orally in a purified form and is used to modify serotonin levels for research.[19] Low brain serotonin level is induced by administration of tryptophan-poor protein in a technique called "acute tryptophan depletion".[57] Studies using this method have evaluated the effect of serotonin on mood and social behavior, finding that serotonin reduces aggression and increases agreeableness.[58] Fluorescence{{Main|Fluorescence spectroscopy#Tryptophan fluorescence}}Tryptophan is an important intrinsic fluorescent probe (amino acid), which can be used to estimate the nature of the microenvironment around the tryptophan residue. Most of the intrinsic fluorescence emissions of a folded protein are due to excitation of tryptophan residues. See also
References1. ^{{cite book | vauthors = Dawson RM | title = Data for Biochemical Research | edition = | publisher = Clarendon Press | location = Oxford | year = 1969 | pages = | isbn = 0-19-855338-2 |display-authors=etal}} 2. ^{{cite web|url=http://www.chem.qmul.ac.uk/iupac/AminoAcid/AA1n2.html|title=Nomenclature and Symbolism for Amino Acids and Peptides|last=|first=|date=|year=1983|website=|publisher=IUPAC-IUB Joint Commission on Biochemical Nomenclature|archiveurl=https://web.archive.org/web/20081009023202/http://www.chem.qmul.ac.uk/iupac/AminoAcid/AA1n2.html|archivedate=October 9, 2008|deadurl=no|accessdate=March 5, 2018}} 3. ^{{cite journal|vauthors=Slominski A, Semak I, Pisarchik A, Sweatman T, Szczesniewski A, Wortsman J|date=2002|title=Conversion of L-tryptophan to serotonin and melatonin in human melanoma cells|url=|journal=FEBS Letters|volume=511|issue=1-3|pages=102–6|doi=10.1016/s0014-5793(01)03319-1|pmid=11821057|via=}} 4. ^{{Cite web|url=https://pubchem.ncbi.nlm.nih.gov/compound/L-tryptophan#section=Ecological-Information|title=L-tryptophan {{!}} C11H12N2O2 - PubChem|last=|first=|date=|website=pubchem.ncbi.nlm.nih.gov|accessdate=December 22, 2016}} 5. ^{{cite journal|last=|first=|vauthors=Fernstrom JD|date=1983|title=Role of precursor availability in control of monoamine biosynthesis in brain|url=http://physrev.physiology.org/cgi/reprint/63/2/484|journal=Physiological Reviews|volume=63|issue=2|pages=484–546|doi=|pmid=6132421|via=}} 6. ^{{cite journal|last=|first=|vauthors=Schaechter JD, Wurtman RJ|date=1990|title=Serotonin release varies with brain tryptophan levels|url=http://wurtmanlab.mit.edu/static/pdf/790.pdf|journal=Brain Research|volume=532|issue=1-2|pages=203–10|doi=10.1016/0006-8993(90)91761-5|pmid=1704290|via=}} 7. ^1 {{cite journal | vauthors = Wurtman RJ, Anton-Tay F | title = The mammalian pineal as a neuroendocrine transducer | journal = Recent Progress in Hormone Research | volume = 25 | issue = | pages = 493–522 | year = 1969 | pmid = 4391290 | doi = 10.1016/b978-0-12-571125-8.50014-4 | url = https://web.archive.org/web/20140531104922/http://wurtmanlab.mit.edu/static/pdf/104.pdf }} 8. ^{{cite journal|last=|first=|vauthors=Ikeda M, Tsuji H, Nakamura S, Ichiyama A, Nishizuka Y, Hayaishi O|date=1965|title=Studies on the biosynthesis of nicotinamide adenine dinucleotide. II. A role of picolinic carboxylase in the biosynthesis of nicotinamide adenine dinucleotide from tryptophan in mammals|url=http://www.jbc.org/cgi/reprint/240/3/1395|journal=The Journal of Biological Chemistry|volume=240|issue=3|pages=1395–401|doi=|pmid=14284754|via=}} 9. ^{{cite journal|last=|first=|vauthors=Palme K, Nagy F|date=2008|title=A new gene for auxin synthesis|url=|journal=Cell|volume=133|issue=1|pages=31–2|doi=10.1016/j.cell.2008.03.014|pmid=18394986|via=}} 10. ^{{cite journal|last=|first=|vauthors=Ledochowski M, Widner B, Murr C, Sperner-Unterweger B, Fuchs D|date=2001|title=Fructose malabsorption is associated with decreased plasma tryptophan|url=https://web.archive.org/web/20160419160203/http://www.lactose.at/pdf/works/11336160.pdf |journal=Scandinavian Journal of Gastroenterology|volume=36|issue=4|pages=367–71|doi=10.1080/003655201300051135|pmid=11336160|via=}} 11. ^{{cite journal | vauthors = Ledochowski M, Sperner-Unterweger B, Widner B, Fuchs D | title = Fructose malabsorption is associated with early signs of mental depression | journal = European Journal of Medical Research | volume = 3 | issue = 6 | pages = 295–8 | date = June 1998 | pmid = 9620891 | doi = }} 12. ^{{cite journal | vauthors = Gollnick P, Babitzke P, Antson A, Yanofsky C | title = Complexity in regulation of tryptophan biosynthesis in Bacillus subtilis | journal = Annual Review of Genetics | volume = 39 | issue = | pages = 47–68 | year = 2005 | pmid = 16285852 | doi = 10.1146/annurev.genet.39.073003.093745 }} 13. ^{{cite book | last1 = Institute of Medicine | title = Dietary Reference Intakes for Energy, Carbohydrates, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids | chapter = Protein and Amino Acids | publisher = The National Academies Press | year = 2002 | location = Washington, DC | pages = 589–768 | url = https://www.nap.edu/read/10490/chapter/12}} 14. ^1 {{cite web|title=Does Turkey Make You Sleepy? | vauthors = Ballantyne C | date=2007-11-21 | url = http://www.scientificamerican.com/article.cfm?id=fact-or-fiction-does-turkey-make-you-sleepy | publisher = Scientific American | accessdate = 2013-06-06 }} 15. ^1 2 {{cite web|url=http://www.ars.usda.gov/ba/bhnrc/ndl|title=USDA National Nutrient Database for Standard Reference, Release 22|author=Holden|first=Joanne|date=|website=|publisher=Nutrient Data Laboratory, Agricultural Research Service, United States Department of Agriculture|accessdate=November 29, 2009}} 16. ^{{cite journal | vauthors = Rambali B, Van Andel I, Schenk E, Wolterink G, van de Werken G, Stevenson H, Vleeming W | title=[The contribution of cocoa additive to cigarette smoking addiction] | journal=RIVM | year=2002 | url = https://web.archive.org/web/20051108071725/http://rivm.nl/bibliotheek/rapporten/650270002.pdf | format=PDF | issue = report 650270002/2002 | publisher = The National Institute for Public Health and the Environment (Netherlands) }} 17. ^{{cite journal | vauthors = Soh NL, Walter GT | title = Tryptophan and depression: can diet alone be the answer? | journal = Acta Neuropsychiatrica VL | volume = 23 | issue = 1 | pages = 1601–5215; | year = 2011 | doi = 10.1111/j.1601-5215.2010.00508.x }} 18. ^{{cite journal|last=|first=|vauthors=Fernstrom JD|date=2012|title=Effects and side effects associated with the non-nutritional use of tryptophan by humans|url=|journal=The Journal of Nutrition|volume=142|issue=12|pages=2236S-2244S|doi=10.3945/jn.111.157065|pmid=23077193|via=}} 19. ^1 {{cite journal|last=|first=|vauthors=Wurtman RJ, Hefti F, Melamed E|date=1980|title=Precursor control of neurotransmitter synthesis|url=|journal=Pharmacological Reviews|volume=32|issue=4|pages=315–35|doi=|pmid=6115400|via=}} 20. ^1 {{cite journal|last=|first=|vauthors=Henderson HE, Devlin R, Peterson J, Brunzell JD, Hayden MR|date=1990|title=Frameshift mutation in exon 3 of the lipoprotein lipase gene causes a premature stop codon and lipoprotein lipase deficiency|url=|journal=Molecular Biology & Medicine|volume=7|issue=6|pages=511–7|pmid=2077351|via=}} 21. ^1 2 {{cite journal | vauthors = Shaw K, Turner J, Del Mar C | title = Tryptophan and 5-hydroxytryptophan for depression | journal = The Cochrane Database of Systematic Reviews | volume = | issue = 1 | pages = CD003198 | year = 2002 | pmid = 11869656 | doi = 10.1002/14651858.CD003198 | editor1-last = Shaw | editor1-first = Kelly A }} 22. ^{{cite journal | vauthors = Ravindran AV, da Silva TL | title = Complementary and alternative therapies as add-on to pharmacotherapy for mood and anxiety disorders: a systematic review | journal = Journal of Affective Disorders | volume = 150 | issue = 3 | pages = 707–19 | date = September 2013 | pmid = 23769610 | doi = 10.1016/j.jad.2013.05.042 }} 23. ^{{cite journal | vauthors = Kimura T, Bier DM, Taylor CL | title = Summary of workshop discussions on establishing upper limits for amino acids with specific attention to available data for the essential amino acids leucine and tryptophan | journal = The Journal of Nutrition | volume = 142 | issue = 12 | pages = 2245S-2248S | date = December 2012 | pmid = 23077196 | doi = 10.3945/jn.112.160846 | url = http://jn.nutrition.org/content/142/12/2245S.long }} 24. ^1 {{cite journal | vauthors = Howland RH | title = Dietary supplement drug therapies for depression | journal = Journal of Psychosocial Nursing and Mental Health Services | volume = 50 | issue = 6 | pages = 13–6 | date = June 2012 | pmid = 22589230 | doi = 10.3928/02793695-20120508-06 }} 25. ^{{cite journal | vauthors = Hopkins FG, Cole SW | title = A contribution to the chemistry of proteids: Part I. A preliminary study of a hitherto undescribed product of tryptic digestion | journal = The Journal of Physiology | volume = 27 | issue = 4–5 | pages = 418–428 | date = December 1901 | pmid = 16992614 | pmc = 1540554 | doi = 10.1113/jphysiol.1901.sp000880 }} 26. ^{{cite journal|doi=10.15227/orgsyn.010.0100 |vauthors=Cox GJ, King H | title = L-Tryptophane | volume= 2 | pages = 612–616 | year = 1943 | url=http://www.orgsyn.org/demo.aspx?prep=CV2P0612|journal=Org. Synth.}} 27. ^{{cite journal|last=|first=|vauthors=Radwanski ER, Last RL|date=1995|title=Tryptophan biosynthesis and metabolism: biochemical and molecular genetics|url=|journal=The Plant Cell|volume=7|issue=7|pages=921–34|doi=10.1105/tpc.7.7.921|pmc=160888|pmid=7640526|via=}} 28. ^{{cite journal | vauthors = Ikeda M | title = Amino acid production processes | journal = Advances in Biochemical Engineering/Biotechnology | volume = 79 | issue = | pages = 1–35 | year = 2002 | pmid = 12523387 | doi = 10.1007/3-540-45989-8_1 | isbn = 978-3-540-43383-5 | series = Advances in Biochemical Engineering/Biotechnology }} 29. ^{{cite journal|last=|first=|vauthors=Becker J, Wittmann C|date=2012|title=Bio-based production of chemicals, materials and fuels -Corynebacterium glutamicum as versatile cell factory|url=|journal=Current Opinion in Biotechnology|volume=23|issue=4|pages=631–40|doi=10.1016/j.copbio.2011.11.012|pmid=22138494|via=}} 30. ^{{cite journal|last=|first=|vauthors=Conrado RJ, Varner JD, DeLisa MP|date=2008|title=Engineering the spatial organization of metabolic enzymes: mimicking nature's synergy|url=|journal=Current Opinion in Biotechnology|volume=19|issue=5|pages=492–9|doi=10.1016/j.copbio.2008.07.006|pmid=18725290|via=}} 31. ^{{cite book|last1=Allen|first1=J.A.|last2=Varga|first2=J|editor1-last=Wexler|editor1-first=Philip|title=Encyclopedia of Toxicology|date=2014|publisher=Elsevier Science|location=Burlington|isbn=978-0-12-386455-0|edition=3rd|chapter=Eosinophilia–Myalgia Syndrome}} 32. ^1 2 3 {{cite web | url = http://www.cfsan.fda.gov/~dms/ds-tryp1.html | archiveurl = https://web.archive.org/web/20050225100757/http://www.cfsan.fda.gov/~dms/ds-tryp1.html | archivedate = 2005-02-25 | title = Information Paper on L-tryptophan and 5-hydroxy-L-tryptophan | date = 2001-02-01 | publisher = FU. S. Food and Drug Administration, Center for Food Safety and Applied Nutrition, Office of Nutritional Products, Labeling, and Dietary Supplements | accessdate = 2012-02-08 }} 33. ^{{cite web |url=http://www.webmd.com/vitamins-and-supplements/l-tryptophan-uses-and-risks#1 |title=L-tryptophan: Uses and Risks |website=WebMD |date=2017-05-12 |access-date=2017-06-05}} 34. ^{{cite news|last1=Altman|first1=Lawrence K.|title=Studies Tie Disorder to Maker of Food Supplement|url=https://www.nytimes.com/1990/04/27/us/studies-tie-disorder-to-maker-of-food-supplement.html|work=The New York Times|date=27 April 1990}} 35. ^{{cite journal|last1=Castot|first1=A|last2=Bidault|first2=I|last3=Bournerias|first3=I|last4=Carlier|first4=P|last5=Efthymiou|first5=ML|title=["Eosinophilia-myalgia" syndrome due to L-tryptophan containing products. Cooperative evaluation of French Regional Centers of Pharmacovigilance. Analysis of 24 cases].|journal=Thérapie|date=1991|volume=46|issue=5|pages=355–65|pmid=1754978}} 36. ^{{cite web|title=COT Statement On Tryptophan and the Eosinophilia-Myalgia Syndrome|url=https://cot.food.gov.uk/sites/default/files/cot/tryptophanamend200401.pdf|publisher=UK Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment|date=June 2004}} 37. ^{{cite journal | vauthors = Slutsker L, Hoesly FC, Miller L, Williams LP, Watson JC, Fleming DW | title = Eosinophilia-myalgia syndrome associated with exposure to tryptophan from a single manufacturer | journal = JAMA | volume = 264 | issue = 2 | pages = 213–7 | date = July 1990 | pmid = 2355442 | doi = 10.1001/jama.264.2.213 }} 38. ^{{cite journal | vauthors = Back EE, Henning KJ, Kallenbach LR, Brix KA, Gunn RA, Melius JM | title = Risk factors for developing eosinophilia myalgia syndrome among L-tryptophan users in New York | journal = The Journal of Rheumatology | volume = 20 | issue = 4 | pages = 666–72 | date = April 1993 | pmid = 8496862 | doi = }} 39. ^{{cite journal | vauthors = Kilbourne EM, Philen RM, Kamb ML, Falk H | title = Tryptophan produced by Showa Denko and epidemic eosinophilia-myalgia syndrome | journal = The Journal of Rheumatology. Supplement | volume = 46 | issue = | pages = 81–8; discussion 89–91 | date = October 1996 | pmid = 8895184 | doi = }} 40. ^{{cite journal | vauthors = Mayeno AN, Lin F, Foote CS, Loegering DA, Ames MM, Hedberg CW, Gleich GJ | title = Characterization of "peak E," a novel amino acid associated with eosinophilia-myalgia syndrome | journal = Science | volume = 250 | issue = 4988 | pages = 1707–8 | date = December 1990 | pmid = 2270484 | doi = 10.1126/science.2270484 }} 41. ^{{cite journal | vauthors = Ito J, Hosaki Y, Torigoe Y, Sakimoto K | title = Identification of substances formed by decomposition of peak E substance in tryptophan | journal = Food and Chemical Toxicology | volume = 30 | issue = 1 | pages = 71–81 | date = January 1992 | pmid = 1544609 | doi = 10.1016/0278-6915(92)90139-C }} 42. ^{{cite journal | vauthors = Smith MJ, Garrett RH | title = A heretofore undisclosed crux of eosinophilia-myalgia syndrome: compromised histamine degradation | journal = Inflammation Research | volume = 54 | issue = 11 | pages = 435–50 | date = November 2005 | pmid = 16307217 | doi = 10.1007/s00011-005-1380-7 }} 43. ^{{cite journal|last1=Allen|first1=JA|last2=Peterson|first2=A|last3=Sufit|first3=R|last4=Hinchcliff|first4=ME|last5=Mahoney|first5=JM|last6=Wood|first6=TA|last7=Miller|first7=FW|last8=Whitfield|first8=ML|last9=Varga|first9=J|title=Post-epidemic eosinophilia-myalgia syndrome associated with L-tryptophan.|journal=Arthritis and Rheumatism|date=November 2011|volume=63|issue=11|pages=3633–9|pmid=21702023|pmc=3848710|doi=10.1002/art.30514}} 44. ^{{cite journal | vauthors = Mayeno AN, Gleich GJ | title = Eosinophilia-myalgia syndrome and tryptophan production: a cautionary tale | journal = Trends in Biotechnology | volume = 12 | issue = 9 | pages = 346–52 | date = September 1994 | pmid = 7765187 | doi = 10.1016/0167-7799(94)90035-3 }} 45. ^{{cite journal | vauthors = Raphals P | title = Does medical mystery threaten biotech? | journal = Science | volume = 250 | issue = 4981 | pages = 619 | date = November 1990 | pmid = 2237411 | doi = 10.1126/science.2237411 }} 46. ^1 {{cite web | vauthors = Helmenstine AM | title = Does Eating Turkey Make You Sleepy? | publisher = About.com | url = http://chemistry.about.com/od/holidaysseasons/a/tiredturkey.htm | accessdate = 2013-11-13}} 47. ^1 {{cite web | vauthors = McCue K | title = Chemistry.org: Thanksgiving, Turkey, and Tryptophan | url = http://www.chemistry.org/portal/a/c/s/1/feature_ent.html?DOC=enthusiasts%5Cent_tryptophan.html | accessdate = 2007-08-17 | archiveurl = https://web.archive.org/web/20070404111342/http://www.chemistry.org/portal/a/c/s/1/feature_ent.html?DOC=enthusiasts%5cent_tryptophan.html | archivedate = 2007-04-04 }} 48. ^{{cite journal | vauthors = | title = Food & mood. (neuroscience professor Richard Wurtman) (Interview) | journal = Nutrition Action Healthletter | publisher = Questia Online Library | volume = | issue = | pages = | doi = | url = https://www.questia.com/read/1G1-12520128 | accessdate= |date=September 1992 }} 49. ^1 {{cite journal | vauthors = Lyons PM, Truswell AS | title = Serotonin precursor influenced by type of carbohydrate meal in healthy adults | journal = The American Journal of Clinical Nutrition | volume = 47 | issue = 3 | pages = 433–9 | date = March 1988 | pmid = 3279747 | doi = | url = https://web.archive.org/web/20070614023349/http://www.ajcn.org/cgi/reprint/47/3/433.pdf }} 50. ^1 2 {{cite journal | vauthors = Wurtman RJ, Wurtman JJ, Regan MM, McDermott JM, Tsay RH, Breu JJ | title = Effects of normal meals rich in carbohydrates or proteins on plasma tryptophan and tyrosine ratios | journal = The American Journal of Clinical Nutrition | volume = 77 | issue = 1 | pages = 128–32 | date = January 2003 | pmid = 12499331 | doi = | url = http://www.ajcn.org/cgi/content/abstract/77/1/128 }} 51. ^1 {{cite journal | vauthors = Afaghi A, O'Connor H, Chow CM | title = High-glycemic-index carbohydrate meals shorten sleep onset | journal = The American Journal of Clinical Nutrition | volume = 85 | issue = 2 | pages = 426–30 | date = February 2007 | pmid = 17284739 | doi = | url = http://www.ajcn.org/cgi/content/full/85/2/426 }} 52. ^1 {{Cite journal|vauthors=Banks WA, Owen JB, Erickson MA|date=2012|title=Insulin in the Brain: There and Back Again|url=|journal=Pharmacology & Therapeutics|volume=136|issue=1|pages=82–93|doi=10.1016/j.pharmthera.2012.07.006|issn=0163-7258|pmc=4134675|pmid=22820012|via=}} 53. ^{{cite journal | vauthors = Pardridge WM, Oldendorf WH | title = Kinetic analysis of blood-brain barrier transport of amino acids | journal = Biochimica et Biophysica Acta | volume = 401 | issue = 1 | pages = 128–36 | date = August 1975 | pmid = 1148286 | doi = 10.1016/0005-2736(75)90347-8 }} 54. ^{{cite journal | vauthors = Maher TJ, Glaeser BS, Wurtman RJ | title = Diurnal variations in plasma concentrations of basic and neutral amino acids and in red cell concentrations of aspartate and glutamate: effects of dietary protein intake | journal = The American Journal of Clinical Nutrition | volume = 39 | issue = 5 | pages = 722–9 | date = May 1984 | pmid = 6538743 | doi = }} 55. ^1 {{cite journal|last=|first=|vauthors=Fernstrom JD, Wurtman RJ|date=1971|title=Brain serotonin content: increase following ingestion of carbohydrate diet|url=|journal=Science|volume=174|issue=4013|pages=1023–5|doi=10.1126/science.174.4013.1023|pmid=5120086|via=}} 56. ^{{cite journal | url = http://www.jbc.org/content/88/3/659.full.pdf | title = A synthesis of tryptophol | vauthors = Jackson RW | journal = Journal of Biological Chemistry | volume = 88 | issue = 3 | pages = 659–662 | year = 1930 }} 57. ^{{cite journal | vauthors = Young SN | title = Acute tryptophan depletion in humans: a review of theoretical, practical and ethical aspects | journal = Journal of Psychiatry & Neuroscience | volume = 38 | issue = 5 | pages = 294–305 | date = September 2013 | pmid = 23428157 | pmc = 3756112 | doi = 10.1503/jpn.120209 }} 58. ^{{cite journal | vauthors = Young SN | title = The effect of raising and lowering tryptophan levels on human mood and social behaviour | journal = Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences | volume = 368 | issue = 1615 | pages = 20110375 | year = 2013 | pmid = 23440461 | pmc = 3638380 | doi = 10.1098/rstb.2011.0375 }} Further reading{{refbegin}}
External links{{refbegin}}
7 : Proteinogenic amino acids|Glucogenic amino acids|Ketogenic amino acids|Aromatic amino acids|Essential amino acids|Tryptamine alkaloids|Dietary supplements |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。